Search for: "AMGEN INC."
Results 221 - 240
of 704
Sort by Relevance
|
Sort by Date
15 Jun 2017, 2:09 pm
In SANDOZ INC. v. [read post]
15 Jun 2017, 2:09 pm
In SANDOZ INC. v. [read post]
14 Jun 2017, 6:37 am
Amgen Inc. [read post]
14 Jun 2017, 4:18 am
” In another Monday ruling, the court held in Amgen Inc. v. [read post]
13 Jun 2017, 4:45 am
’” Finally, in Amgen Inc. v. [read post]
12 Jun 2017, 9:59 pm
Amgen Inc., marking the first time the Court has interpreted the Biologics Price Competition and Innovation Act ("BPCIA") for the approval of biosimilar drugs. [read post]
12 Jun 2017, 3:18 pm
Amgen Inc. and Bachem in Greener Reaction Conditions - Green Process for Commercial Manufacture of Etelcalcetide Enabled by Improved Technology for Solid Phase Peptide Synthesis Amgen Inc. worked with Bachem to improve the manufacturing process for the active ingredient in ParsabivTM, a drug that treats secondary hyperparathyroidism in adult patients with chronic kidney disease. [read post]
12 Jun 2017, 12:15 pm
Amgen Inc., regarding the Biologics Price Competition and Innovation Act of 2009. [read post]
12 Jun 2017, 8:02 am
Amgen Inc., No. 15-1039. [read post]
6 Jun 2017, 9:04 pm
By Andrew Williams -- On May 25, 2017, the FDA's Oncologic Drug Advisory Committee recommended approval of biologics license application ("BLA") 125545 submitted by Hospira Inc., a Pfizer company, for Retacrit, a proposed biosimilar to Amgen Inc.'s Epogen/Procrit (epoetin alfa). [read post]
18 May 2017, 1:55 pm
This so-called "Dear Doctor" letter about Aranesp also informed that Health Canada is currently working with the manufacturer, Amgen Canada Inc., to include this safety information in the Canadian Product Monograph for Aranesp. [read post]
17 May 2017, 4:10 am
Amgen Inc., and Henson v. [read post]
1 May 2017, 4:10 am
Last week, the court heard oral argument in Amgen Inc. v. [read post]
30 Apr 2017, 4:30 am
Regulatory approval, trade secrets and the transatlantic biosimilars patent wars | Biosimilars and generics as "rip-offs": when the facts may not matter | UK's IP Enforcement Framework - IPO Research Bid Opportunity | Curtain - Merpel's final EPO post | Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans | BREAKING: Politico publishes (part of) draft copyright report by MEP Comodini Cachia | Parallel… [read post]
28 Apr 2017, 1:17 pm
Amgen Inc. [read post]
28 Apr 2017, 6:01 am
Amgen and Amgen v. [read post]
27 Apr 2017, 9:35 pm
Amgen Inc. from Sandoz counsel (Deanne E. [read post]
26 Apr 2017, 9:59 pm
Amgen Inc. [read post]
26 Apr 2017, 7:16 pm
Amgen Inc., No. 15-1039. [read post]
26 Apr 2017, 3:19 pm
In Amgen Inc. v. [read post]
